EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis

Linjuan Sun, Nan Ouyang, Shaheryar Shafi iD, Rongchuan Zhao, Jinlin Pan, Lei Hong, Xueyan Song, Xiaohan Sa, Yuanshuai Zhou iD

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338231161141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Linjuan Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering (Suzhou), 12652University of Science and Technology of China, Hefei, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Epithelial-Mesenchymal Transition, Nuclear Respiratory Factor 1, Anoikis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nuclear respiratory factor 1 (NRF1) is an important regulator involved in mitochondrial biogenesis and energy metabolism. However, the specific mechanism of NRF1 in anoikis and epithelial-mesenchymal transition (EMT) remains unclear.

Methods

We examined the effect of NRF1 on mitochondria and identified the specific mechanism through transcriptome sequencing, and explored the relationships among NRF1, anoikis, and EMT.

Results

We found that upregulated NRF1 expression led to increased mitochondrial oxidative phosphorylation (OXPHOS) and ATP generation. Simultaneously, a significant amount of ROS is generated during OXPHOS. Alternatively, NRF1 upregulates the expression of ROS-scavenging enzymes, allowing tumor cells to maintain low ROS levels and promoting anoikis resistance and EMT. We also found that exogenous ROS was maintained at a low level by NRF1 in breast cancer cells. Conclusion: our study provides mechanistic insight into the function of NRF1 in breast cancer, indicating that NRF1 may serve as a therapeutic target for breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEpithelial-Mesenchymal TransitionNuclear Respiratory Factor 1AnoikisHumansFemaleCell Line, TumorOxidative PhosphorylationHomeostasisAdenosine TriphosphateMitochondriaMembrane Potential, MitochondrialReactive Oxygen Species

Stichwörter der Autor:innen

EMTNRF1OXPHOSROSanoikisbreast cancer

Substanzen

NRF1 protein, humanNuclear Respiratory Factor 1Adenosine TriphosphateReactive Oxygen Species

Autor:innen und Institutionen

  • School of Biomedical Engineering (Suzhou), 12652University of Science and Technology of China, Hefei, China.
  • 165085Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, China.

ORCID-Profile: Shaheryar Shafi, Yuanshuai Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, L., Ouyang, N., Shafi, S., Zhao, R., Pan, J., Hong, L., Song, X., Sa, X., & Zhou, Y. (2023). NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338231161141

Vancouver

Sun L, Ouyang N, Shafi S, Zhao R, Pan J, Hong L, et al. NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338231161141

BibTeX
@article{Sun2023,
  author = {Sun, Linjuan and Ouyang, Nan and Shafi, Shaheryar and Zhao, Rongchuan and Pan, Jinlin and Hong, Lei and Song, Xueyan and Sa, Xiaohan and Zhou, Yuanshuai},
  title = {NRF1 Regulates the Epithelial Mesenchymal Transition of Breast Cancer by Modulating ROS Homeostasis},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338231161141}
}
Kostenlos starten →